.png){kind=icon}
返回
Developments in clinical cell therapy
.png){kind=icon}
OA
AI
DOI：10.3109/14653240903511952.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Immunotherapy has become an important part of hematopoietic stem cell (HSC) transplantation and cancer therapy. Regenerative and reparative properties of somatic cell-based therapies hold tremendous promise for repairing injured tissue, preventing and reversing damage to organs, and restoring balance to compromised immune systems. The principles and practices of the diverse aspects of immune therapy for cancer, HSC transplantation and regenerative medicine have many commonalities. This meeting report summarizes a workshop sponsored by the National Heart, Lung and Blood Institute (NHLBI) and Production Assistance for Cellular Therapies (PACT), held on 23-24 April 2009 at the National Institutes of Health (NIH, USA). A series of scientific sessions and speakers highlighted key aspects of the latest scientific, clinical and technologic developments in cell therapy, involving a unique set of cell products with a special emphasis on converging concepts in these fields.
Keyword:
cancer
cell therapy
hematopoietic stem cell transplantation
regenerative medicine
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.2
论文数:
4.6K
被引数:
6.7K
机构
引用论文
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma:: In vivo persistence, migration, and antitumor effect of transferred T cells使用抗原特异性CD8 T细胞克隆的过继性T细胞疗法治疗转移性黑色素瘤患者: 转移T细胞的体内持久性，迁移和抗肿瘤作用OAAI
OAAI分享收藏Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells间充质干细胞移植促进造血干细胞植入.png)
LEUKEMIA
LEUKEMIAIF13.4
PREAI
分享收藏Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cellsCYTOTHERAPYOAAI
CYTOTHERAPYIF3.2
OAAI分享收藏分享收藏分享收藏
查看更多内容